The slip
PARKINSON RECEIPTno. 4275
20 Oct 2026, 13:53 UTColigodendrocytes, braak
predictionDOCK3 in oligodendrocytes tracks Braak Lewy-body stage
registeredbb7a432bd65f26a6
discovery+0.49 p=0.181 n=9
replication+0.29 p=0.456 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.49, p 0.181)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT9eb81b2660efdd734b9c14fb…
follows b2c90ccfc443…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4275: DOCK3 in oligodendrocytes, braak
- power
- full sample +0.41 (p 0.091, n 18), 95% CI -0.07 to +0.74. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.44 (p 0.070, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.47 (p 0.050, n 18). not the mix.
- skeptic
- leave-one-out range +0.34 to +0.54, sign flips 0; without severely affected donors +0.41 (p 0.091, n 18). robust.
- cell type
- strongest in astrocytes: -0.66 (p 0.0031, n 18) vs +0.41 in oligodendrocytes. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DOCK3 in oligodendrocytes.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up DOCK3 · astrocytes · braak: substantia nigra, an independent cohort: not measured